GL1X · GenesisL1 explorer

Research workbench

Structure of human PARP1 catalytic domain bound to a quinazoline-2, 4(1H,3H)-dione inhibitor

Analyse Structure of human PARP1 catalytic domain bound to a quinazoline-2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5WRY
Type
protein
Length
703 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase 1
EC
2.4.2.30
UniProt
P09874
Ligands
4YR
Pockets
5 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 39% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APoly [ADP-ribose] polymerase 1 (EC 2.4.2.30)protein35139% helix, 25% strandP09874
BPoly [ADP-ribose] polymerase 1 (EC 2.4.2.30)protein35239% helix, 23% strandP09874

Ligands and binding sites

  • 4YR · N-[(3R)-1-(cyclopropylmethyl)pyrrolidin-3-yl]-5-[(2,4-dioxo-3,4-dihydroquinazolin-1(2H)-yl)methyl]-2-fluorobenzamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17160.820.86744YR
24550.800.88464YR
31810.530.7928empty
4640.490.8514empty
5770.470.8320empty

Interfaces

1 interface between chains.

  • A–B · 973 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 5WRY · Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.